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Chitooligosaccharides (COS) are derivatives of chitosan, typi-
cally differing from native chitosan by having a molecular weight
of 10 kDa or less. They have recently attracted attention as poten-
tial therapeutic agents, owing to a variety of reported positive bio-
logical activities (Eaton, Fernandes, Pereira, Pintado, & Malcata,
2008; Kim & Rajapakse, 2005), and have shown potential as scav-
enging agents, due to their ability to abstract hydrogen atoms from
free radicals (Huang, Mendis, & Kim, 2005; Vårum, Ottøy, &
Smidsrød, 1994). This ability has been reported as directly corre-
lated with their structural properties – namely that the amino
and hydroxyl groups can react with unstable free radicals to form
stable macromolecule radicals (Je, Park, & Kim, 2004; Kim & Rajap-
akse, 2005). Furthermore, their ready uptake by cells and the intes-
tine, in addition with their claimed low toxicity, make
chitooligosaccharides very promising compounds for use as natu-
ral antioxidants (Chae, Jang, & Nah, 2005; Fernandes et al., 2008).
Although several studies on chitosans and COS already reported
antioxidant activity, so far most reports are based on methods
which measure the capacity of a molecule to reduce a stable artiﬁ-
cial free radical: scavenging of DPPH or ABTS radicals, carbon cen-
tered radical scavenging, hydroxyl or superoxide radical assays,
and metal ion chelating (Anraku et al., 2009; Feng, Du, Li, Wei, &
Yao, 2007; Guzman, Saucedo, Revilla, Navarro, & Guibal, 2003;
Park, Je, & Kim, 2004; Pasanphan & Chirachanchai, 2008; Rao,
Chander, & Sharma, 2008). In addition, lipid peroxidation and pro-
tein oxidation inhibition assays, as well as a DNA protection assay
by agarose gel electrophoresis have been also used to study chito-
san or COS scavenging ability (Huang et al., 2005; Prashanth, Dhar-
mesh, Rao, & Tharanathan, 2007; Yan et al., 2007). When studying
antioxidant activities, the method used should be representative of
in situ conditions. Therefore, in the work described here, the anti-
oxidant activity of two COS mixtures and of a low MW chitosan
(LMWC) has been evaluated using two biological oxidizable sub-
strates – erythrocytes and phages, subjected to accelerated oxida-
tive conditions.Chitooligosaccharide mixtures characterized by two distinct
molecular weights – <3 and <5 kDa and possessing a degree of
deacetylation in the range 80–85% were purchased from Nicechem
(Shanghai, China). Low MW chitosan with 107 kDa and possessing
a degree of deacetylation in the range 80–85%, was obtained from
Sigma–Aldrich (Sintra, Portugal). All the compounds were derived
from crab shells. The stock preparations of phage P22 and Salmo-
nella typhimurium were obtained according to ATCC indications,
Ref. 19585 B1. All the chemicals used in this work were purchased
from Sigma–Aldrich (Sintra, Portugal).
ABTS [2,2-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)]
radical cation assay (ABTS+). The radical scavenging capacity of
both COS mixtures and of LMWC was evaluated against ABTS rad-
ical cations generated by a previously reported protocol (Gião
et al., 2007). This method is based on the ability of antioxidant
molecules to quench the long-lived ABTS+ species, a blue-green
chromophore with a characteristic absorption at 734 nm. The addi-
tion of antioxidants to the preformed radical cation reduces it to
ABTS, causing a loss of color. The assay was performed in triplicate.
Results were expressed by plotting % of inhibition versus com-
pound concentration, and were also expressed as equivalent con-
centration of ascorbic acid (in mg/mL) for purposes of
standardization.
The antioxidant capacity of both COS mixtures and of LMWC
was evaluated via the biological system P22/S. typhimurium, as de-
scribed previously by Gião et al. (2009).
Firstly the effect of 250 mM of H2O2 on the action of the phage
on S. typhimurium was determined. Like the later assays, this was
done by incubating the phage with the oxidant for 20 min, taking
aliquots each 5 min. The activity of these treated phages on S.
typhimuriumwas then determined by plate counting, giving results
in PFU mL1. The effects of the potential antioxidants were re-
ported relative to the effect of H2O2 alone. The phages were treated
as described above, but in the presence of both the H2O2 and the
COS mixture or LMWC under study at several different concentra-
tions (1.0, 0.1, 0.05, 0.01, 0.005 and 0.001 mg/mL). The antioxidant
effect is reported as the difference between the log PFU mL1 mea-
sured with the compound and the oxidant, and that measured with
only the oxidant.Blood was obtained from healthy volunteers by venipuncture
and collected into tubes containing EDTA as an anticoagulant. Sam-
ples were immediately centrifuged at 405g for 10 min; plasma and
buffy coat were carefully removed and discarded. RBCs were
washed three times with phosphate buffered saline (PBS;
125 mM NaCl and 10 mM sodium phosphate buffer, pH 7.4) at
4 C and ﬁnally resuspended in PBS, to obtain an RBC suspension
at 2% (v/v) hematocrit.
The hemolysis assays were performed by using H2O2 or 2,20-
azobis (2-amidinopropane) hydrochloride – AAPH as the oxidant
agent at a ﬁnal concentration of 7.5 mM (or 60 mM), with or with-
out ascorbic acid at its physiological concentration (in accordance
with the hematocrit used – 3 lM). In all sets of experiments (n = 4),
a negative control (RBCs in PBS, with no oxidant) was used, as well
as compound controls (RBCs in PBS, with each compound at each
concentration). We calculated the hemolysis induced by the com-
pounds at each concentration, and used this as a baseline result.
These values were below 3% hemolysis for all concentrations and
compounds tested (Fernandes et al., 2008). The results are pre-
sented as percentages relative to the control hemolysis values.
All control and sample tests were run in duplicate. Incubations of
RBC suspensions were carried out at 37 C for 3 h, under gentle
shaking. Hemolysis was determined spectrophotometrically,
according to the protocol described in Ko, Hsiao, and Kuo (1997).
After the incubation period, an aliquot of the RBC suspension
was taken out, diluted with 20 volumes of saline and centrifuged
(1180g for 10 min). The absorption of the supernatant (A) was read
at 540 nm. To yield the absorption of a complete hemolysis (B), the
RBC suspension was treated with 20 volumes of ice cold distilled
water and, after centrifugation the absorption of the supernatant
was measured at the same wavelength. The percentage of hemoly-
sis was then calculated as (A/B)  100.
In order to analyze Hb oxidation, visible absorption spectra
(500–700 nm) were measured using hemolysates incubated with
different concentrations of COS/LMWC for 3 h, either in the pres-
ence of AAPH (60 mM) or H2O2 (7.5 mM), as described by Colado
Simão et al. (2006).Mean values and standard deviations were calculated from the
experimental data obtained, and analysis of variance (ANOVA) was
applied at a 5% level of signiﬁcance, using compound concentration
and MW as main factors. Pairwise comparisons were done using
the Bonferroni test, at the same level of signiﬁcance.The results of the total antioxidant capacity assay using ABTS
are shown in Fig. 1. These results were also calibrated based on
the antioxidant capacity of ascorbic acid, and this is shown in Ta-
ble 1. All the three studied compounds displayed antioxidant activ-
ities as they were able to scavenge the ABTS+. All three compounds
displayed a positive correlation between the concentration of com-
pound added and the level of inhibition. These results show that in
terms of TAC value, the <3 kDa and <5 kDa COS had almost identi-
cal effects, while LMWC showed lower activity at all concentra-
tions (maximum activities were 0.301 and 0.298 gL1 equivalent
of ascorbic acid for <3 and <5 kDa, and 0.223 gL1 for LMWC).
The inactivation curve of P22 bacteriophage, which was at-
tained by adding 250 mM of H2O2, clearly shows a reduction in
the number of available phages to infect S. typhimurium during
the course of the experiment (Fig. 2). After 20 min, a 3-log cycle
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Fig. 1. Concentration–response curve for inhibition of the absorbance of ABTS+ at
734 nm after 6 min, at different concentrations of COS (<3 and <5 kDa) and LMWC.
Table 1
Total antioxidant capacity expressed as equivalent concentration of ascorbic acid
(average ± standard deviation) of the three compounds, determined at 6 min.
Concentration
(mg/mL)
<3 kDa COS <5 kDa COS LMWC
TAC (mg/mL)
1.0 0.3010 ± 0.0045 0.2986 ± 0.0051 0.2237 ± 0.0056
0.5 0.1968 ± 0.0013 0.1968 ± 0.0003 0.1614 ± 0.0020
0.1 0.1398 ± 0.0019 0.1424 ± 0.0009 0.1055 ± 0.0003
0.05 0.1029 ± 0.0016 0.1045 ± 0.0010 0.0698 ± 0.0013
0.01 0.0794 ± 0.0045 0.0669 ± 0.0006 0.0358 ± 0.0007
0.005 0.0472 ± 0.0013 0.0431 ± 0.0007 0.0183 ± 0.0001
0.001 0.0107 ± 0.0003 0.0109 ± 0.0003 0.0103 ± 0.0007
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Fig. 3. Results of bacteriophage/S. typhimurium assays, expressed as the difference
between log PFU mL1 measured in the presence of the oxidant and that measured
in the presence of the oxidant plus the antioxidant system.reduction in the initial number of phages was achieved. This 3-log
reduction after 20 min was used as a control in order to analyze the
antioxidant activity of both COS compounds and the LMWC. By
adding 1.0 mg/mL of any of the compounds under study, an
enhancement in the oxidant effect of H2O2 upon the phage was ob-
served (Fig. 3). A somewhat decreased effect was observed for both
COS mixtures at 0.1 mg/mL, while LMWC simply did not present
any effect at that concentration. However, none of the compounds
at these concentrations exhibited themselves damage to the phage.
A signiﬁcant protection of phage P22 against oxidation was ob-
served when 0.05 or 0.01 mg/mL of COS were added (statistically
different, for both concentrations, from LMWC values, p < 0.05).
At these concentrations both COS compounds led to an enhance-
ment of phage numbers of around 1 log cycle, which indicates a
protection rate of approximately 90%. For concentrations below
0.01 mg/mL the antioxidant activity was absent for both COS, how-
ever, LMWC still maintained a slight protective effect (ca. 0.1-log
cycle at 0.005 mg/mL).
In the presence of H2O2, all the three compounds signiﬁcantly
protected RBCs from oxidative-induced hemolysis at concentra-6
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Fig. 2. Bacteriophage inactivation curve, obtained with the oxidant system
(250 mM H2O2) on the P22 bacteriophage.tions between 0.05 and 0.005 mg/mL (statistically similar between
them, p > 0.05). The strength of antioxidant activity was in the or-
der LMWC >3 kDa COS >5 kDa COS (as shown in Fig. 4). At lower
concentrations the protection by all the three compounds de-
creased considerably (to around 10%, but only statistically different
from 0.01 mg/mL, p < 0.05). For the highest tested concentration
(1.0 mg/mL), the hemolysis inhibition was so little as to be almost
meaningless (p < 0.005, when compared with hemolysis inhibition
provided at 0.05 and 0.005 mg/mL); nevertheless, LMWC showed
three times higher inhibition at this concentration than both COS
compounds (p > 0.05).
In order to simulate in vivo conditions, the compounds were
also tested in the presence of 3 lM ascorbic acid. Only when the
concentrations were between 0.05 and 0.005 mg/mL, was some
additive protection effect observed. Only the results within this
range are shown in Fig. 5, since the results at concentrations above
0.05 and below 0.005 mg/mL were not promising, even with the
compounds alone (Fig. 4). The mixture of <3 kDa COS (0.05 mg/
mL) and ascorbic acid showed the highest protection (almost
55%), and was the only result signiﬁcantly different to ascorbic acid
alone (p < 0.05). Within this concentration range all the other re-
sults were similar to the effect of ascorbic acid by itself (39.5%).
In addition, ascorbic acid plus any of the COS mixtures at 1 mg/
mL potentiated the oxidant effect of H2O2 (data not shown).
When AAPH was used as oxidative agent (Fig. 6), all the three
compounds signiﬁcantly protected the RBCs from hemolysis, ex-
cept at the highest concentration studied. At this concentration
(1 mg/mL), LMWC showed a small protective effect (5% – statisti-
cally not signiﬁcant when compared with all other LMWC concen-
trations tested) and the COS compounds potentiated the oxidation
slightly (p < 0.005). Once again, the highest inhibition was con-
ferred by concentrations between 0.05 and 0.005 mg/mL. Within
the active concentration range, the <3 and <5 kDa COS compounds
showed similar activities (p > 0.05) and the LMWC a somewhat
lower activity. The highest protection rate was achieved by
<3 kDa COS at 0.005 mg/mL – 24.9% hemolysis inhibition, while
LMWC never attained an inhibition above 14.0%.0
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Fig. 4. Percentage of inhibition of lysis of RBCs at 2% hematocrit incubated for 3 h
with 7.5 mM of H2O2 and COS/LMWC at different concentrations. Mean (error bars
represent range) of four determinations for each duplicate.
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Fig. 5. Percentage of inhibition of lysis of RBCs at 2% hematocrit incubated for 3 h
with 7.5 mM of H2O2 and COS/LMWC at different concentrations, in the presence of
ascorbic acid (3 lM). Mean (error bars represent range) of four determinations for
each duplicate.
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Fig. 6. Percentage of inhibition of lysis of RBCs at 2% hematocrit incubated for 3 h
with 60 mM of AAPH and COS/LMWC at different concentrations. Mean (error bars
represent range) of four determinations for each duplicate.
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Fig. 8. Spectral scans (500–650 nm) of lysed RBC suspensions, obtained after 3 h of
incubation in: (a) PBS; (b) the presence of AAPH (60 mM); (c) the presence of AAPH
(60 mM) with 0.005 mg/mL of <3 kDa COS; (d) the presence of AAPH (60 mM) with
0.005 mg/mL of LMWC.The results obtained on inhibition of hemolysis by AAPH in the
presence of ascorbic acid are shown in Fig. 7. In the presence of
ascorbic acid, the potentiation of AAPH oxidant effect at high con-
centrations was not observed (data not shown); nevertheless, the
protection rate observed was lower than that observed for ascorbic
acid alone (36.5% by <3 kDa COS; 34.3% by <5 kDa; 52.9% by ascor-
bic acid). Similarly to the protection against H2O2, the best protec-
tion rates were observed at the compound concentrations between
0.05 and 0.005 mg/mL. At 0.005 mg/mL, <3 kDa COS showed a
hemolysis inhibition of 68.7%, while <5 kDa COS and LMWC pre-
sented relatively lower percentages – 59.0% and 61.5%, respec-
tively. In general, with or without ascorbic acid, <3 kDa COS
presented the highest protection against AAPH. However, none of
the results showed signiﬁcant differences to that afforded by ascor-
bic acid alone (p > 0.05).
By performing spectral scans of RBC lysates (obtained after 3 h
of incubation at 37 C in the presence of AAPH or H2O2 and with or0
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Fig. 7. Percentage of inhibition of lysis of RBCs at 2% hematocrit incubated for 3 h
with 60 mM of AAPH and COS/LMWC at different concentrations, in the presence of
ascorbic acid (3 lM). Mean (error bars represent range) of four determinations for
each duplicate.without the compounds under study), changes could be observed
in the oxy-hemoglobin peaks (540 and 578 nm) when compared
with the control assay (RBCs without the oxidative agents). Repre-
sentative spectra are compared in Fig. 8. When AAPH was added, a
considerable decrease in the size of the oxy-hemoglobin peaks was
evident, even with the addition of COS or LMWC. However, a high-
er level of oxy-hemoglobin remained when any of the COS was
added at 0.05 or 0.005 mg/mL. On the contrary, when 1.0 mg/mL
was used, the oxy-hemoglobin peaks were lower than those of
AAPH (data not shown). Regarding LMWC, oxy-hemoglobin peaks
were always lower than those following treatment by AAPH alone,
independently of the concentration tested. When the analysis was
carried out using H2O2 as the oxidant, the reduction in size of both
oxy-hemoglobin peaks was greater (data not shown). Although a
small protection could be seen with the addition of COS (at 0.05
or 0.005 mg/mL) or LMWC (for all concentrations), none of the
compounds effectively protected hemoglobin from oxidation. In
fact, a meta-hemoglobin peak (630 nm) appeared in all cases, ex-
cept in the control. Both COS at 1.0 mg/mL increased to a small ex-
tent the hemoglobin oxidation (data not shown).
The results of the ABTS assay showed clearly that the three
compounds possess the capacity to reduce ABTS+ in a dose-depen-
dent manner. In addition, it suggests that this capacity is greater in
COS, as in every concentration tested (down to 0.005%), a 10% high-
er inhibition percentage was measured, compared to inhibition by
LMWC. Other authors have described similar results for similar
(chemical) assays: Several authors have shown dose-dependent
radical scavenging by COS (Huang et al., 2005; Feng et al., 2007)
and some authors also found that greater molecular weight COS
compounds were more effective, matching our results (Feng
et al., 2007). Park et al. (2004) reported that the scavenging activity
was dependent on the number of amino groups available (degree
of acetylation). Considering that the three tested compounds pos-
sess a similar degree of acetylation, the dose-dependent activity
observed is justiﬁed by the increasing amount of amino groups
with increasing concentrations. However, for the same concentra-
tion, the difference observed between both COS compounds and
the LMWC suggests that an important role may be associated to
the chain length.
Bacteriophage populations can be progressively inactivated by a
number of environmental stresses. This inactivation can be re-
vealed by assaying the viable phage population prior to and follow-
ing stress (Gião et al., 2009). Phage inactivation can represent a
sensitive approach to measure the effects of oxidative stress on
the biological integrity of DNA. Alternatively, it might also reﬂect
damage to the proteinaceous phage capsid, such that the DNA can-
not be delivered. Our results showed that both tested COS can
effectively protect phage P22 against oxidative damage by H2O2,
for a certain range of concentrations (0.05–0.01 mg/mL). Higher
concentrations seem to potentiate the H2O2 action. It is well-estab-
lished that for nearly all antioxidant compounds studied, prooxi-
dant effects are found when the compounds are used at very
high concentrations (Gião et al., 2009; Otero, Viana, Herrera, &
Bonet, 1997; Park et al., 2008). In light of the scarcity of knowledge
of the antioxidant activity of chitooligosaccharides, the mechanism
of such prooxidant effects is unknown.
The protection effect exhibited by LMWCwas lower than the at-
tained by COS; nevertheless, it was shown be more effective at
lower concentrations (0.005 mg/mL) and to potentiate H2O2 effect,
to a lesser extent, at higher concentrations.
In order to further elucidate the antioxidant properties of COS/
LMWC in human cells, RBC were selected as a metabolically simpli-
ﬁed model system. These blood cells can act as cumulative markers
of oxidative stress in vitro and in vivo, providing information about
oxidative damage suffered and accumulated by the cell over its
lifespan or during in vitro assays. If ROS are overproduced outside
or within the erythrocyte, or if the endogenous antioxidant de-
fenses are impaired, an oxidative stress condition will develop,
inducing oxidative damage on erythrocyte constituents, including
the membrane and Hb, which may lead ultimately to hemolysis.
We tested the efﬁcacy of COS/LMWC as inhibitors of H2O2- and
AAPH-induced RBC hemolysis. Hydrogen peroxide crosses the RBC
membrane and is known to react with Hb, generating highly reac-
tive radical species including hydroxyl radicals (Ko et al., 1997).
Our results suggest that COS and LMWC have the capacity to pro-
tect RBC from such H2O2-induced hemolysis, by scavenging hydro-
xyl radicals. However, similarly to the results observed for the
phage assay, the level of inhibition obtained for this system was
lower than those reported by others authors that used strictly
chemical methodologies: for example, Chien, Sheu, Huang, and
Su (2007) showed that at 1.0 mg/mL, a 12 kDa chitosan exhibited
90.5% scavenging activity toward hydrogen peroxide, while ascor-
bic acid and a 95 kDa chitosan presented 87.4% and 75.0%, respec-
tively. On the contrary, at this concentration we obtained the
lowest inhibition rate measured (lower than 10% for any of the
three compounds). A possible justiﬁcation could be the adhesion
and/or aggregation reactions between RBCs and COS, observed
for COS concentrations above or equal to 0.1 mg/mL, as directly ob-
served in our previous work (Fernandes et al., 2008). These reac-
tions between COS (at higher concentrations) and RBCs may lead
to weakness of the RBC membranes, since it interferes with some
RBC membrane proteins that are responsible for the cytoskeleton
maintenance (Fernandes et al., 2008).
When RBC suspensions are prepared for the assays, the exoge-
nous plasmatic antioxidant defenses are washed out during the
manipulation. Therefore, in order to understand the effective pro-
tection of compounds against oxidative-induced injury in RBCs,
their activity was also tested in the presence of the most important
extracellular antioxidant, the ascorbic acid. It is important to bear
in mind that antioxidant substances work together in vivo, not
alone. In the presence of a physiological concentration of ascorbic
acid, no synergetic effect was observed, but an additive one. The
protection achieved by the mixture of either COS or LMWC with
ascorbic acid may be considered as a good indicator for physiolog-
ical activity, since at moderate concentrations, they signiﬁcantly
protected the RBCs from H2O2-induced oxidation, especially the
<3 kDa COS.
In contrast to H2O2, AAPH-radicals attack RBC membrane com-
ponents, causing membrane damage (peroxidation of phospholip-
ids) eventually leading to hemolysis (Colado Simão et al., 2006; Ko
et al., 1997). AAPH is a hydrophilic radical initiator producing per-
oxyl/alkoxyl radicals at physiological temperatures in the presence
of molecular oxygen, which can induce lipid peroxidation (Volpi &Tarugi, 1997). Such peroxyl radicals have been identiﬁed as the
main secondary carriers of biological damage (Anraku et al.,
2009). Our results suggest that COS or LMWC have the ability to
protect cells from these radicals (when in moderate concentrations
– 0.05–0.005 mg/mL), but were less effective than against H2O2-in-
duced oxidation. However, the combination of COS/LMWC with
ascorbic acid showed a very promising effect on the protection of
human cells from these radicals (ca. 60–70%), attaining values
more comparable to those reported by chemical methods.
Although there is no information on the sites of attack by peroxyl
radicals on chitosans, several studies reported a higher scavenging
activity upon these radicals by chitosans with higher deacetylation
degree (Anraku et al., 2009; Park et al., 2004), suggesting impor-
tance of the D-glucosamine units in the process.
Finally, the Hb oxidation assays revealed that none of the com-
pounds tested effectively protected Hb from oxidation by H2O2.
However, oxidation of Hb by AAPH was considerably reduced by
both COS mixtures. The absence of protection against H2O2 proba-
bly results from the fact that Hb oxidation processes occur intracel-
lularly, where COS or LMWC cannot play their protective effect (Ko
et al., 1997). The H2O2-generated radicals that COS/LMWC is not
able to eliminate outside the RBC may cross the RBC membrane
and react with Hb. On the other hand, as AAPH-radicals attack
the membrane but do not cross the membrane, the Hb oxidation
only occurred after RBC have been lysed. Therefore, the external
COS or LMWCmolecules were able to scavenge AAPH-radicals pre-
venting Hb oxidation.
Our results suggest that chitooligosaccharides can be used as
antioxidants in biological systems. All the tested compounds re-
duced both the hemolytic and DNA damage, by inhibiting H2O2-
and AAPH-radicals. However, on the contrary to the results ob-
tained with chemical methodologies, our data suggested that
COS/LMWC concentrations have to be reasonably low in order to
prevent enhancement of the oxidative damage. Furthermore, the
comparison of the results using different methodologies clearly
highlights the need for testing antioxidant properties of biological
substrates; chemical methods alone may suggest misleadingly
high antioxidant activities.
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